| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reviews |

T Cells in Tumor Immunology
1 Institute of Immunology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany and 2 Department of Immunology, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, P.R. China
Requests for reprints: Dieter Kabelitz, Institute of Immunology, University Hospital Schleswig-Holstein Campus Kiel, Michaelisstr. 5, D-24105 Kiel, Germany. Phone: 49-431-5973340; Fax: 49-431-5973335; E-mail: kabelitz{at}immunologie.uni-kiel.de.
Subsets of human 
T cells recognize tumor cellexpressed ligands that are not seen by the T-cell receptor of conventional
ß T cells. V
1 T cells recognize MHC class I chainrelated molecules A and B and UL-16binding proteins expressed at variable levels on epithelial tumor cells and some leukemias and lymphomas. In addition, therapeutically used aminobisphosphonates and synthetic phosphoantigens activate V
2 T cells, the dominant subset of 
T cells in human peripheral blood that display strong cytotoxicity towards various epithelial tumors. Intentional activation of 
T cells in vivo and/or adoptive cell therapy with in vitro expanded 
T cells holds considerable promise as a novel immunotherapy in certain types of cancer. [Cancer Res 2007;67(1):58]
This article has been cited by other articles:
![]() |
G. Gruenbacher, H. Gander, A. Rahm, W. Nussbaumer, N. Romani, and M. Thurnher CD56+ human blood dendritic cells effectively promote TH1-type {gamma}{delta} T-cell responses Blood, November 12, 2009; 114(20): 4422 - 4431. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, W. Wu, W. M. Wong, E. Ward, A. J. Thrasher, D. Goldblatt, M. Osman, P. Digard, D. H. Canaday, and K. Gustafsson Human {gamma}{delta} T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis J. Immunol., November 1, 2009; 183(9): 5622 - 5629. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qi, M. Xia, J. Hu, E. Hicks, A. Iyer, N. Xiong, and A. August Enhanced development of CD4+ {gamma}{delta} T cells in the absence of Itk results in elevated IgE production Blood, July 16, 2009; 114(3): 564 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, M. J. Herold, B. Kimmel, I. Muller, B. Rincon-Orozco, V. Kunzmann, and T. Herrmann Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by V{gamma}9V{delta}2 T Cells J. Immunol., June 15, 2009; 182(12): 8118 - 8124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Todaro, M. D'Asaro, N. Caccamo, F. Iovino, M. G. Francipane, S. Meraviglia, V. Orlando, C. La Mendola, G. Gulotta, A. Salerno, et al. Efficient Killing of Human Colon Cancer Stem Cells by {gamma}{delta} T Lymphocytes J. Immunol., June 1, 2009; 182(11): 7287 - 7296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gertner-Dardenne, C. Bonnafous, C. Bezombes, A.-H. Capietto, V. Scaglione, S. Ingoure, D. Cendron, E. Gross, J.-F. Lepage, A. Quillet-Mary, et al. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies Blood, May 14, 2009; 113(20): 4875 - 4884. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Devaud, E. Bilhere, S. Loizon, V. Pitard, C. Behr, J.-F. Moreau, J. Dechanet-Merville, and M. Capone Antitumor Activity of {gamma}{delta} T Cells Reactive against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model Cancer Res., May 1, 2009; 69(9): 3971 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Lataillade, O. Pierre-Louis, H. C. Hasselbalch, G. Uzan, C. Jasmin, M.-C. Martyre, M.-C. Le Bousse-Kerdiles, and on behalf of the French INSERM and the European EU Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence Blood, October 15, 2008; 112(8): 3026 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, X. He, Z. Wang, D. Wu, H. Zhang, C. Xu, H. He, L. Cui, D. Ba, and W. He Identification of Human T Cell Receptor {gamma}{delta}-recognized Epitopes/Proteins via CDR3{delta} Peptide-based Immunobiochemical Strategy J. Biol. Chem., May 2, 2008; 283(18): 12528 - 12537. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, I.-E. A. Eltoum, B. Guo, B. H. Beck, G. A. Cloud, and R. D. Lopez Protective Immunosurveillance and Therapeutic Antitumor Activity of {gamma}{delta} T Cells Demonstrated in a Mouse Model of Prostate Cancer J. Immunol., May 1, 2008; 180(9): 6044 - 6053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Holderness, L. Jackiw, E. Kimmel, H. Kerns, M. Radke, J. F. Hedges, C. Petrie, P. McCurley, P. M. Glee, A. Palecanda, et al. Select Plant Tannins Induce IL-2R{alpha} Up-Regulation and Augment Cell Division in {gamma}{delta} T Cells J. Immunol., November 15, 2007; 179(10): 6468 - 6478. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dieli, D. Vermijlen, F. Fulfaro, N. Caccamo, S. Meraviglia, G. Cicero, A. Roberts, S. Buccheri, M. D'Asaro, N. Gebbia, et al. Targeting Human {gamma}{delta} T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer Cancer Res., August 1, 2007; 67(15): 7450 - 7457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |